Lisinopril and Hydrochlorothiazide
- Product NDC
- 50090-6094
- 11-digit product format
- 500906094
- Labeler code
- 50090
- Product ID
- 50090-6094_bb097f51-4333-4c3a-bc5d-47471ae66240
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide Tablets
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA204058
- Marketing category
- ANDA
- Marketing start
- 2019-12-26
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 12.5; 10 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| E7199S1YWR | LISINOPRIL | 83915-83-7 | LISINOPRIL |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6094-0 | 50090609400 | 30 TABLET in 1 BOTTLE (50090-6094-0) | 30 tablet | 2022-09-22 | No | No | Historical |
| 50090-6094-1 | 50090609401 | 90 TABLET in 1 BOTTLE (50090-6094-1) | 90 tablet | 2022-09-22 | No | No | Historical |
| 50090-6094-2 | 50090609402 | 100 TABLET in 1 BOTTLE (50090-6094-2) | 100 tablet | 2023-11-14 | No | No | Historical |